What is Ognomy Sleep?
Ognomy Sleep operates at the intersection of telehealth and specialized medicine, providing a comprehensive digital platform for the diagnosis and management of sleep disorders. By facilitating remote consultations and home-based diagnostic testing, the company effectively removes traditional barriers to entry for patients seeking sleep healthcare. Its model integrates clinical expertise with digital care management, allowing for personalized treatment plans that improve patient outcomes while reducing the reliance on in-person clinical visits. As a leader in the virtual sleep medicine space, Ognomy is redefining the standard of care for individuals suffering from chronic sleep-related conditions.
How much funding has Ognomy Sleep raised?
Ognomy Sleep has raised a total of $41.7M across 3 funding rounds:
Angel/Seed
$6.8M
Stock/Share Issuance
$14.9M
Series A
$20M
Angel/Seed (2024): $6.8M with participation from Impellent Ventures
Stock/Share Issuance (2026): $14.9M, investors not publicly disclosed
Series A (2026): $20M supported by Excell Partners, Impellent Ventures, Catalyst Investors, UB University at Buffalo, Blue Heron Capital, and Launch NY
Key Investors in Ognomy Sleep
Excell Partners
Excell is a venture capital fund that invests in high-tech, high-growth startups in New York State, particularly in Upstate NY. The fund focuses on generating top-quartile returns while supporting regional economic development by providing entrepreneurs with both capital and hands-on support.
Impellent Ventures
Impellent Ventures is a venture capital firm that invests in preseed and seed stage companies, providing up to $1.5M in funding. With an operator-first mentality, the firm is focused on supporting bold and adventurous startups by leveraging their extensive experience in building and growing companies.
Catalyst Investors
Catalyst Investors is a growth equity firm located in New York that specializes in actively helping B2B companies scale their operations and achieve their full potential. With over 20 years of experience, they provide strategic, tactical, and financial support to entrepreneurs during critical growth phases.
What's next for Ognomy Sleep?
With the recent influx of capital, Ognomy Sleep is expected to prioritize the expansion of its clinical network and the refinement of its digital diagnostic tools. The strategic focus will likely shift toward enhancing operational efficiency and scaling its enterprise-level service offerings to meet the needs of a broader patient demographic. By utilizing the expertise of its growth-oriented backers, the company is well-equipped to navigate the complexities of the healthcare landscape, potentially exploring new partnerships and technological integrations that will further streamline the patient journey from initial evaluation to long-term therapeutic support.
See full Ognomy Sleep company page
